Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLVN.L Regulatory News (BLVN)

  • There is currently no data for BLVN

Board Appointment

22 Jul 2024 07:00

RNS Number : 1110X
Bowleven plc
22 July 2024
 

 

 

 

22nd July 2024

 

 

Bowleven plc ('Bowleven')

Board Appointment

Bowleven plc ("Bowleven" or the "Company") announces that Mark Vermeulen has been appointed as a Non-Executive Director with immediate effect.

 

Mark is a partner, Chief Investment Officer and fund manager at Ophorst van Marwijk Kooy Vermogensbeheer NV ("OVMK"), a value-oriented investment firm focussed on both mid and small-cap equities in the UK, Hong Kong and Europe, and high-yield bonds. He has spent the last 15 years managing a range of international bond and value funds for OVMK, with significant exposure to oil & gas related investments. He has previously worked at Dresdner Bank as an analyst across a number of international equity funds. Mark is a CFA Charterholder.

 

Eli Chahin, CEO of Bowleven, commented:

"We are delighted to welcome Mark to the Board. Mark brings his extensive financial, corporate and governance experience. His appointment is complementary to the existing Board as we together continue to focus on the overall strategy of establishing Etinde as the foremost project development in Cameroon."

 

Further information in accordance with Rule 17 and paragraph (g) of Schedule Two of the AIM Rules for Companies (the "AIM Rules") is set out at the end of this announcement.

 

ENQUIRIES

 

For further information, please contact:

 

Bowleven plc

 

Eli Chahin, Chief Executive

+ 44 20 3327 0150

 

Camarco (Financial PR)

Owen Roberts

+ 44 20 3757 4980

Hugo Liddy

Shore Capital (NOMAD and Broker)

Daniel Bush

Rachel Goldstein

+ 44 20 7408 4090

 

 

 

 

Appendix - Rule 17 and Schedule Two (g) disclosures

 

Save for the information set out above and below, there are no further disclosures to be made in accordance with Rule 17 and Schedule Two paragraph (g) of the AIM Rules in respect of the appointment of Markus (Mark) Franciscus Antonius Vermeulen, aged 41. Mark does not hold a direct interest in the Company's ordinary share capital; however, OVMK, of which Mark is a partner and fund manager, manages an interest in 14,779,175 shares on behalf of its clients, representing 0.78% of the Company's total issued ordinary share capital (excluding shares held in treasury).

 

 

Current Directorships/Partnerships

Ophorst van Marwijk Kooy Vermogensbeheer NV

Podere Fignano SNC

 

Past Directorships/Partnerships (within 5 years)

N/A

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOARLMTTMTBBBLI
Date   Source Headline
15th Jan 20135:35 pmRNSHolding(s) in Company
14th Jan 20134:08 pmRNSHolding(s) in Company
14th Jan 20133:56 pmRNSHolding(s) in Company
20th Dec 20128:22 amRNSHolding(s) in Company
12th Dec 20121:06 pmRNSRESULT OF GENERAL MEETING
12th Dec 20121:05 pmRNSResult of AGM
11th Dec 20128:24 amRNSConditional vesting of 2009 LTIP Awards
26th Nov 20127:00 amRNSEEAA submitted
19th Nov 20125:00 pmRNSPosting of Annual Report and Accounts
9th Nov 20127:00 amRNSHolding(s) in Company
8th Nov 20125:58 pmRNSHolding(s) in Company
6th Nov 20127:03 amRNSPetrofac Agrees Strategic Alliance with Bowleven
6th Nov 20127:00 amRNSPreliminary Results Announcement
6th Nov 20127:00 amRNSEtinde Strategic Alliance
17th Sep 20127:00 amRNSGroup Operations Update
3rd Sep 20127:00 amRNSBlocklisting Interim Review
31st Jul 20128:00 amRNSTotal Voting Rights
16th May 20122:45 pmRNSChange of Registered Office
30th Apr 20127:00 amRNSTotal Voting Rights
24th Apr 20122:41 pmRNSFerrostaal MOU Execution Announcement
16th Apr 20124:33 pmRNSHolding(s) in Company
16th Apr 20127:00 amRNSGBP1.05 million for Bowleven Contract Win
4th Apr 20122:19 pmRNSHolding(s) in Company
2nd Apr 201211:35 amRNSHolding(s) in Company
30th Mar 20128:48 amRNSCompletion of Sale of Interest in EOV Permit
30th Mar 20127:00 amRNSTotal Voting Rights
26th Mar 20127:00 amRNSInterim Results Announcement
16th Mar 20122:54 pmRNSHolding(s) in Company
9th Mar 20121:47 pmRNSHolding(s) in Company
2nd Mar 201211:47 amRNSHolding(s) in Company
29th Feb 20123:13 pmRNSForm 8 (DD) - BowLeven Plc RELEASED IN ERROR
29th Feb 201211:57 amRNSForm 8.5 (EPT/RI)
29th Feb 201211:49 amBUSForm 8.5 (EPT/NON-RI) BOWLEVEN PLC
29th Feb 201211:42 amRNSForm 8 (DD) - BowLeven Plc
29th Feb 201210:54 amRNSForm 8.5 (EPT/NON-RI) Bowleven Plc
29th Feb 201210:19 amRNSHolding(s) in Company
29th Feb 20127:00 amRNSTotal Voting Rights
28th Feb 20123:44 pmRNSStatement re Dragon Oil announcement
28th Feb 20123:29 pmRNSForm 8.3 - Bowleven Plc
28th Feb 20123:28 pmRNSStatement re Bowleven plc
28th Feb 20123:09 pmRNSForm 8.3 - Bowleven PLC
28th Feb 201211:46 amRNSForm 8 (OPD) - BowLeven PLC
28th Feb 201211:43 amBUSFORM 8.5 (EPT/NON-RI) - BOWLEVEN PLC
28th Feb 201211:35 amRNSForm 8.5 (EPT/NON-RI) Bowleven Plc
28th Feb 201211:29 amRNSForm 8.5 (EPT/RI)
28th Feb 201210:47 amRNSForm 8.3 - Bowleven PLC
28th Feb 20129:54 amRNSForm 8.5 (EPT/RI)- Amendment
27th Feb 20124:16 pmBUSForm 8.5 (EPT/NON-RI) Bowleven Plc
27th Feb 20123:27 pmRNSForm 8.3 - BowLeven Plc
27th Feb 20122:54 pmRNSForm 8.3 - BowLeven PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.